SGLT2 inhibitor-induced glycosuria improves steatotic liver disease in parallel with enhanced ureagenesis in ob/ob mice.
Saved in:
| Title: | SGLT2 inhibitor-induced glycosuria improves steatotic liver disease in parallel with enhanced ureagenesis in ob/ob mice. |
|---|---|
| Authors: | Kidoguchi S; Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: s.kidoguchi@jikei.ac.jp., Kitada K; Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan., Morishita A; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa, Japan., Tsuji Y; Department of Biomedical Molecular Sciences, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Ohsaki H; Department of Medical Biophysics, Kobe University Graduate School of Health Science, Kobe, Japan., Yamazaki D; Division of Nephrology and Hypertension, Osaka City General Hospital, Osaka, Japan., Morikawa T; Division of Nephrology and Hypertension, Osaka City General Hospital, Osaka, Japan., Konishi Y; Division of Nephrology and Hypertension, Osaka City General Hospital, Osaka, Japan., Kobara H; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa, Japan., Yokoo T; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan., Titze J; Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore; )Division of Nephrology and Hypertension, Friedrich-Alexander University Erlangen-Nuremberg, Germany; Division of Nephrology, Duke University Medical Center, Durham, NC, USA., Takahashi K; Center for Joint Research Facilities Support, Research Promotion and Support Headquarters, Fujita Health University School of Medicine, Toyoake, Aichi, Japan., Nishiyama A; Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan. |
| Source: | Journal of pharmacological sciences [J Pharmacol Sci] 2026 Feb; Vol. 160 (2), pp. 122-131. Date of Electronic Publication: 2025 Dec 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Japanese Pharmacological Society Country of Publication: Japan NLM ID: 101167001 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1347-8648 (Electronic) Linking ISSN: 13478613 NLM ISO Abbreviation: J Pharmacol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41554596 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: SGLT2 inhibitor-induced glycosuria improves steatotic liver disease in parallel with enhanced ureagenesis in ob/ob mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kidoguchi+S%22">Kidoguchi S</searchLink>; Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: s.kidoguchi@jikei.ac.jp.<br /><searchLink fieldCode="AU" term="%22Kitada+K%22">Kitada K</searchLink>; Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Morishita+A%22">Morishita A</searchLink>; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Tsuji+Y%22">Tsuji Y</searchLink>; Department of Biomedical Molecular Sciences, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Ohsaki+H%22">Ohsaki H</searchLink>; Department of Medical Biophysics, Kobe University Graduate School of Health Science, Kobe, Japan.<br /><searchLink fieldCode="AU" term="%22Yamazaki+D%22">Yamazaki D</searchLink>; Division of Nephrology and Hypertension, Osaka City General Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Morikawa+T%22">Morikawa T</searchLink>; Division of Nephrology and Hypertension, Osaka City General Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Konishi+Y%22">Konishi Y</searchLink>; Division of Nephrology and Hypertension, Osaka City General Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kobara+H%22">Kobara H</searchLink>; Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Yokoo+T%22">Yokoo T</searchLink>; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Titze+J%22">Titze J</searchLink>; Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore; )Division of Nephrology and Hypertension, Friedrich-Alexander University Erlangen-Nuremberg, Germany; Division of Nephrology, Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Takahashi+K%22">Takahashi K</searchLink>; Center for Joint Research Facilities Support, Research Promotion and Support Headquarters, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Nishiyama+A%22">Nishiyama A</searchLink>; Department of Pharmacology, Faculty of Medicine, Kagawa University, Kagawa, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101167001%22">Journal of pharmacological sciences</searchLink> [J Pharmacol Sci] 2026 Feb; Vol. 160 (2), pp. 122-131. <i>Date of Electronic Publication: </i>2025 Dec 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Japanese+Pharmacological+Society%22">Japanese Pharmacological Society </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>101167001 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1347-8648 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213478613%22">13478613 </searchLink><i>NLM ISO Abbreviation: </i>J Pharmacol Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41554596 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jphs.2025.12.006 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 122 Titles: – TitleFull: SGLT2 inhibitor-induced glycosuria improves steatotic liver disease in parallel with enhanced ureagenesis in ob/ob mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kidoguchi S – PersonEntity: Name: NameFull: Kitada K – PersonEntity: Name: NameFull: Morishita A – PersonEntity: Name: NameFull: Tsuji Y – PersonEntity: Name: NameFull: Ohsaki H – PersonEntity: Name: NameFull: Yamazaki D – PersonEntity: Name: NameFull: Morikawa T – PersonEntity: Name: NameFull: Konishi Y – PersonEntity: Name: NameFull: Kobara H – PersonEntity: Name: NameFull: Yokoo T – PersonEntity: Name: NameFull: Titze J – PersonEntity: Name: NameFull: Takahashi K – PersonEntity: Name: NameFull: Nishiyama A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1347-8648 Numbering: – Type: volume Value: 160 – Type: issue Value: 2 Titles: – TitleFull: Journal of pharmacological sciences Type: main |
| ResultId | 1 |
